Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.

@article{Lev2010ClinicalUA,
  title={Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.},
  author={Irina Lev and Gauri Kelekar and Alan D. Waxman and Run Yu},
  journal={Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists},
  year={2010},
  volume={16 3},
  pages={398-407}
}
OBJECTIVE To examine the indications for metaiodobenzylguanidine (MIBG) scintigraphy and to assess its performance in localizing pheochromocytoma in the post-computed tomography and magnetic resonance imaging era. METHODS In this retrospective study, electronic and paper medical records of patients who underwent MIBG scintigraphy at a large academic hospital in Los Angeles, California, between January 1995 and July 2009 were reviewed for indications for MIBG scintigraphy, clinical history… CONTINUE READING